Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse
出版年份 2013 全文链接
标题
Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse
作者
关键词
-
出版物
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 48, Issue 7, Pages 839-847
出版商
Informa UK Limited
发表日期
2013-06-24
DOI
10.3109/00365521.2013.793389
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TMC435 for the treatment of chronic hepatitisC
- (2012) Sudeep Tanwar et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Association between interleukin-28B-related genetic variants and liver histopathology differs between hepatitis C virus genotypes
- (2012) Karolina Rembeck et al. HEPATOLOGY
- Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2–6: TMC435-C202, a phase IIa, open-label study
- (2012) Christophe Moreno et al. JOURNAL OF HEPATOLOGY
- Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Histopathology in Chronic Hepatitis C Genotype 2 and 3
- (2012) Karolina Rembeck et al. PLoS One
- Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3
- (2012) Åsa Alsiö et al. PLoS One
- Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C
- (2012) Peer Brehm Christensen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment
- (2011) Annarosa Floreani et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- IL28Bgenetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
- (2011) Amir Moghaddam et al. HEPATOLOGY
- IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes
- (2011) Pierre-Yves Bochud et al. HEPATOLOGY
- IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
- (2011) P.-Y. Bochud et al. JOURNAL OF HEPATOLOGY
- Interleukin 28B Gene Variation at rs12979860 Determines Early Viral Kinetics During Treatment in Patients Carrying Genotypes 2 or 3 of Hepatitis C Virus
- (2011) Magnus Lindh et al. JOURNAL OF INFECTIOUS DISEASES
- IL28Bpolymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1
- (2011) M. Lindh et al. JOURNAL OF VIRAL HEPATITIS
- Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms
- (2011) Martin Lagging et al. PLoS One
- Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection
- (2010) Martin Lagging et al. HEPATOLOGY
- Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?
- (2010) Martin Lagging et al. JOURNAL OF HEPATOLOGY
- Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
- (2009) Thierry Poynard et al. GASTROENTEROLOGY
- The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients
- (2009) Robert Flisiak et al. HEPATOLOGY
- Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C
- (2009) Galia Askarieh et al. HEPATOLOGY
- Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection
- (2008) Alessandra Mangia et al. HEPATOLOGY
- Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection
- (2008) Martin Lagging et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started